Banerjee, R., Allen, J., Lin, S. G., Westenhouse, J., Desmond, E., Schecter, G. F., . . . Flood, J. (2010). Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California. Journal of clinical microbiology, 48(10), 3779. https://doi.org/10.1128/JCM.01236-10
Chicago-Zitierstil (17. Ausg.)Banerjee, Ritu, et al. "Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-resistant Tuberculosis in California." Journal of Clinical Microbiology 48, no. 10 (2010): 3779. https://doi.org/10.1128/JCM.01236-10.
MLA-Zitierstil (9. Ausg.)Banerjee, Ritu, et al. "Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-resistant Tuberculosis in California." Journal of Clinical Microbiology, vol. 48, no. 10, 2010, p. 3779, https://doi.org/10.1128/JCM.01236-10.